Mechanisms of Drug Resistance in Epilepsy: Novartis Foundation Symposium 243

Mechanisms of Drug Resistance in Epilepsy: Novartis Foundation Symposium 243

Editor(s): Gregory Bock, Jamie A. Goode

Published Online: 7 OCT 2008

Print ISBN: 9780470841464

Online ISBN: 9780470846353

DOI: 10.1002/0470846356

Series Editor(s): Novartis Foundation

About this Book

The object of this book is to gather together workers in the fields of epilepsy, those concerned with the basic science of resistance and the blood-brain barrier, and those with clinical experience of drug resistance in cancer, with a view to stimulating further work on drug resistance in epilepsy. Whilst resistance in cancer has been extensively studied, and trials of reversal of resistance have been undertaken, with some success, resistance in epilepsy has only just begun to be addressed.

Table of contents

    1. You have free access to this content
    2. Drug Resistance in Epilepsy: The Role of the Blood–Brain Barrier (pages 38–53)

      N. Joan Abbott, Ehsan U. Khan, Christopher M. S. Rollinson, Andreas Reichel, Damir Janigro, Stephen M. Dombrowski, Michael S. Dobbie and David J. Begley

    3. Reversal of Multidrug Resistance: Lessons from Clinical Oncology (pages 83–102)

      Susan E. Bates, Clara Chen, Robert Robey, Min Kang, William D. Figg and Tito Fojo

    4. Drug Resistance in Epilepsy: Human Epilepsy (pages 167–179)

      S. M. Sisodiya, W.-R. Lin, B. N. Harding, M. V. Squier and M. Thom

    5. You have free access to this content

SEARCH